Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-2qfjpvPhase 4Not yet recruiting
Phase 4, open-label trial in human immunodeficiency virus infection (HIV) (5 arms), sponsored by Departamento de Medicina Preventiva, Faculdade de Medicina, Universidade de São Paulo. Primary endpoint: Protective effect of sexual post-exposure prophylaxis. Planned start Sep 2015; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-2qfjpv.